Norwest Venture Partners, established in 1961, is a global venture capital and growth equity firm based in Palo Alto, California. With nearly $5 billion under management, the firm invests in early to late-stage companies across various sectors, including technology, business services, financial services, consumer products, and healthcare. Norwest focuses on providing capital and operational support to help CEOs and founders scale their businesses, with typical investments ranging from $10 million to $50 million, and sometimes up to $100 million for growth equity companies. The firm has invested in over 600 companies and currently partners with over 140 active companies across its portfolio.
Principal, Head of Mergers Acquisitions and Capital Markets
Yoni Braun
Vice President
Sonya Brown
General Partner and Co-Head of Growth Equity
Shiv Chaudhary
Managing Director, Norwest India
Priti Youssef Choksi
Partner
Casper De Clercq
General Partner
Nathan Cohen
Vice President
Jeffrey Crowe
Co-Founder and Senior Managing Partner
Ran Ding
Partner
Matthew De Dominicis
Administrative Partner and CFO
Philip Fleischman
Vice President
David Glaser
Investor
Anubha Goyal
Investor, Norwest India
Ken Graham
Investor
Aidan Greenstein
Investor
Guillermo Grimaldo
Investor
Garrett Hardesty
Investor
Ryan Harris
General Partner
Sean Jacobsohn
Partner
Trey Jennings
Senior Associate
Krish Kapadia
Vice President
Sameer Kapur
Vice President, Growth Equity
Paul Kigawa
Investor
Nikhil Kookada
Vice President
Jon Kossow
Co-Founder and Managing Partner
Parul Laddha
Investor, Norwest India
Jordan Leites
Vice President
Sam Lesser
Investor
Sonia Li
Associate
Brian Matesic
Principal
Cassie McHenry
Investor
JP McKeever
Investor
John McNeil
Investor
Ryan McDonald
Principal - Healthcare
Scott Mitchell
Principal
Venkat Mohan
Operating Partner and Board Member
Brian Moon
Senior Associate
Dror Nahumi
General Partner
Michelle Nie
Investor
Ginny Pan
Investor
Connor Pike
Principal, Growth Equity
Ankit Prasad
Vice President
Irem Rami
Principal, Growth Equity and Venture
Ashwin Ravi
Associate
Gabrielle Rush
Investor
Samuel Saldarriaga
Investor
Umang Sanghvi
Investor, Norwest India
Christopher Scullin
Vice President
Rama Sekhar
Partner
Suraj Shah
Vice President
Niren Shah
Managing Director and Head of India, Norwest Venture Partners (NVP) India
Chris Sondej
Principal, Growth Equity
Gabe Stauber
Associate
Laurie Tennant
Principal, People Advisory
Matthew Uthupan
Investor
Sanchana Vasikaran
Investor
Vidushi Verma
Investor, Norwest India
Jessica Yi
Vice President
Edward Yip
Partner
Michael Zarian
Investor
Justin Zhang
Investor
David Zilberman
General Partner
Dave Zilberman
General Partner
972 past transactions
Veza
Series D in 2025
Veza is the data security platform that helps users use and share their data safely. It makes it easy to understand, manage, and control who can and should take what action on what data. It organizes authorization metadata across identity providers, data systems, cloud service providers, and applications, all to address the toughest data security challenges of the modern era. The company is funded by top-tier investors including Accel, Bain Capital, Ballistic Ventures, Blackstone, GV, Norwest Venture Partners, and True Ventures.
Power Exchange
Venture Round in 2025
Power Exchange is a power market infrastructure institution providing electronic platform for transactions in power and allied products.
BuildVision
Series A in 2025
BuildVision is a technology company specializing in construction procurement solutions. It offers a digital platform that facilitates the sourcing, bidding, financing, and tracking of construction materials and equipment. The platform leverages data-driven insights and collaboration with suppliers to enhance procurement efficiency, automate repetitive tasks, and streamline communications. This results in cost reduction, improved efficiency, and accelerated project scheduling for businesses in the construction industry.
SetPoint Medical
Venture Round in 2025
SetPoint Medical is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices aimed at treating chronic autoimmune diseases. The company is creating a platform that stimulates the vagus nerve to activate the body's natural inflammatory reflex, leading to a systemic immune-restorative effect. This innovative approach offers an alternative treatment option for conditions such as rheumatoid arthritis and inflammatory bowel disease, with the potential for reduced risks and costs compared to traditional drug therapies. SetPoint Medical, originally known as Innovative Metabolics Inc. until its name change in 2008, aims to provide patients and healthcare providers with effective solutions for managing debilitating inflammatory diseases.
Rain
Series A in 2025
Rain is a finance company that provides credit card services with technical support for secure transactions to web3 and crypto companies.
LlamaIndex
Series A in 2025
LlamaIndex is a developer of a flexible data framework that facilitates the integration of custom data sources with large language models (LLMs). The company's central interface toolkit enables businesses to connect unstructured, structured, or semi-structured data, allowing for the creation of robust end-user applications. By providing a simple solution for augmenting LLM applications with external data, LlamaIndex empowers organizations to leverage their unique data assets effectively.
Callio Therapeutics
Series A in 2025
Callio Therapeutics specializes in the development of advanced antibody-drug conjugates (ADCs) for cancer treatment. Their focus lies in creating multi-payload ADCs, which allow for the targeted delivery of drug combinations directly to tumor cells. This innovative approach aims to maximize therapeutic benefits and improve patient outcomes.
Guidde
Series A in 2025
Guidde is a knowledge management platform that facilitates efficient knowledge transfer for businesses, enhancing both team productivity and customer interactions. The platform enables users to collaboratively create, maintain, organize, and share video-based content that is context-aware and accessible at the point of need. By streamlining the processes of capturing and distributing knowledge, Guidde helps teams shorten the time it takes for customers to understand and utilize solutions, while also supporting continuous upskilling for employees and partners. Its innovative approach is utilized by various teams, including Customer Success, Pre Sales, and Product teams, to improve operational effectiveness and knowledge collaboration.
ICON
Series C in 2025
ICON is a construction technologies company that focuses on revolutionizing homebuilding through the use of 3D printing, robotics, software, and advanced materials. The company specializes in constructing single-story, mid-size homes, particularly in developing countries, allowing for faster and more cost-effective building compared to traditional methods. By leveraging innovative technologies, ICON aims to address the housing needs of underserved communities, streamlining the construction process for engineers and builders alike.
Pinkfish
Pre Seed Round in 2025
Pinkfish simplifies enterprise automation creation by allowing users to describe workflows in natural language.
tvScientific
Series B in 2025
TvScientific is a performance advertising platform focused on making connected TV (CTV) advertising accessible and measurable for brands and applications of all sizes. The platform utilizes data to demonstrate the true value of TV advertising while simplifying and automating the processes of CTV buying and optimization. TvScientific offers real-time reporting that allows users to monitor campaign performance effectively, ensuring that their advertising efforts achieve optimal results. Additionally, the platform features Always-On Incrementality testing, which provides insights into the incremental value generated by CTV campaigns, further assuring users that their marketing strategies are effective. By combining intuitive campaign management with digital-like measurement and attribution, TvScientific enables businesses to harness CTV as a scalable performance channel.
TrustLogix
Seed Round in 2025
TrustLogix focuses on enhancing digital transformation by providing comprehensive solutions for enterprise data security and privacy. The company develops an analytics platform that streamlines cloud data security operations, enabling businesses to implement and enforce fine-grained access controls across various data platforms, including major services like Google Cloud and Azure. Its offerings include automated data privacy controls, audit reporting, and compliance verification, which help organizations effectively manage data access for users in data science, analytics, and business intelligence. By centralizing observability and governance, TrustLogix simplifies the complexities of data security, allowing companies to safeguard their information assets while ensuring regulatory compliance.
BAKENAI
Seed Round in 2025
BAKEN AI is a partner specializing in practical AI solutions and strategies for small and medium-sized enterprises (SMEs). They offer services such as customized AI briefings, an AI Kickstart program that includes readiness assessments and responsible policy development, and integrations like Nmbrs & BambooHR to enhance HR processes. Their mission is to empower businesses of all sizes by effectively leveraging data, acting as a bridge between technology, strategy, and operations. Based in Amsterdam Zuid, they invite clients for meetings over coffee and provide contact options for inquiries.
Ouro Medicines
Series A in 2025
Ouro Medicines is a biotechnology company dedicated to immunology, focusing on treating chronic, immune-mediated illnesses. It specializes in integrating scientific knowledge and clinical trial experience to develop innovative, cell-depleting therapies. The company's core technology involves T cell engager antibodies that target and eliminate specific pathogenic cells, aiming to provide extended remissions for patients without the need for continuous immunosuppression.
Optiflow
Seed Round in 2024
OptiflowAPI is a tech startup empowering e-commerce businesses with real-time logistics optimization. Our core product, a cutting-edge API, leverages a proprietary geospatial-temporal reinforcement learning algorithm to dramatically improve delivery efficiency and reduce costs. As a digital-native company, we offer a pure SaaS solution, providing seamless integration and unparalleled performance with sub-50ms latency. Reduce delivery times by up to 20% and fuel costs by 15% with OptiflowAPI's intelligent route and resource allocation.
Nuvig Therapeutics
Series B in 2024
Nuvig Therapeutics is focused on developing innovative therapies aimed at restoring immune homeostasis and rebalancing immune function, particularly following inflammation. The company is building a pipeline of novel immune therapeutics specifically designed for chronic inflammatory and autoimmune diseases. By leveraging natural mechanisms to modulate immune responses, Nuvig seeks to enhance treatment options available to healthcare providers and improve patient outcomes.
Zelis
Private Equity Round in 2024
Zelis is a healthcare and financial technology company that specializes in claims cost management and payments optimization solutions. Founded in 2016 and based in Bedminster, New Jersey, Zelis provides integrated services such as network analytics, payment integrity, electronic payments, and claims communications. These offerings aim to streamline the pricing, payment, and explanation of healthcare claims for payers, healthcare providers, and consumers across medical, dental, and workers' compensation markets. By leveraging advanced technology, Zelis assists its clients in navigating the complexities of the healthcare financial landscape while ensuring compliance with evolving regulations. The company is supported by investment firms Parthenon Capital Partners and Bain Capital.
Montara
Seed Round in 2024
Montara is an AI-driven data development platform that streamlines the entire data lifecycle for data teams, including engineers and analysts. It offers a comprehensive suite of tools for data transformation, modeling, validation, and pipeline management, as well as features for data lineage, cataloging, and observability. By integrating these capabilities into a single platform, Montara enhances collaboration among stakeholders, enabling them to deliver improved data products more efficiently. Additionally, the platform automates the management of cloud infrastructure, providing solutions for monitoring, provisioning, and optimizing resources. Utilizing advanced algorithms for predictive scaling and cost management, Montara helps businesses improve operational efficiency while adapting to changing workloads and growth.
Divi
Venture Round in 2024
Divi is an e-commerce company specializing in the manufacture and sale of hair care products. Its primary focus is on producing high-quality, vegan products that target scalp health. Key ingredients include peppermint oil for soothing, tea tree oil for removing build-up, and menthol to promote blood circulation.
Third Wave Automation
Series C in 2024
Third Wave Automation, Inc. specializes in developing autonomous forklift technology that leverages machine learning and computer vision to enhance material handling. Founded in 2018 and based in Union City, California, the company has created a Shared Autonomy Platform that allows forklifts to perform intricate tasks under the supervision of human operators, who can intervene as necessary. This approach improves safety and operational efficiency within warehouses and supply chains. By integrating advanced robotics and deep learning, Third Wave Automation's solutions facilitate precise automated movement of materials and adapt to varying warehouse configurations and demands, thereby enhancing overall throughput and effectiveness in logistics operations.
Finova Capital
Series E in 2024
Finova Capital is a non-banking financial company focused on providing loans to micro and small businesses. The company aims to enhance access to finance for enterprises often overlooked by traditional banks, offering personalized financing options that include detailed insights into loan structures and payment plans. By prioritizing transparency and affordability, Finova Capital helps these businesses meet their production needs and achieve their financial goals.
Vridhi Home Finance
Series B in 2024
Vridhi Home Finance is a housing finance company that leverages technology to expand its reach and serve customers in tier two and three cities across India. It focuses on providing affordable housing finance to underserved and unserved populations, helping them secure loans to purchase or build their dream homes. The company aims to improve the standard of living for its customers by facilitating homeownership.
InvestMind AI
Seed Round in 2024
InvestMind AI revolutionizes investment strategies through advanced AI technology, providing tailored insights and recommendations for smarter financial decisions in a complex market landscape.
CytoVale
Series D in 2024
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
ClarityFlow AI
Seed Round in 2024
ClarityFlow AI is dedicated to revolutionizing customer support services through artificial intelligence technology, offering 24/7 intelligent chatbot solutions that seamlessly integrate with human agents. This approach enhances customer experiences across various industries by providing efficient and timely responses. The intelligent chatbots improve customer response efficiency while ensuring a smooth integration with human support, ultimately delivering a superior support experience
xtype
Series A in 2024
xtype is a developer of a DevOps platform tailored for ServiceNow developers and administrators, focusing on enhancing productivity, security, and compliance in software development. The company offers a value stream platform that facilitates the automation of deployment and release processes, allowing clients to streamline production releases. By leveraging various packages that include update sets, data, scripts, XML, plugins, and store applications, xtype's solutions enable users to build robust and secure business applications efficiently. The platform's graphical interface minimizes the need for extensive coding, making it accessible for users to manage and optimize their development workflows effectively.
ShiraTronics
Series B in 2024
ShiraTronics, Inc. is a company that specializes in developing and commercializing neuromodulation therapies aimed at treating chronic migraines, a condition that significantly impacts the lives of millions worldwide. Founded in 2018 and headquartered in Ireland, with an additional location in Minneapolis, Minnesota, ShiraTronics is focused on addressing unmet clinical needs in neurology. The company's innovative technologies offer new approaches to effectively alleviate the debilitating effects of migraine headaches, thereby striving to improve the quality of life for those affected by this disabling disorder.
Route 92
Series F in 2024
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.
MBX Biosciences
Series C in 2024
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.
Courier Health
Series A in 2024
Courier Health is a developer of a patient engagement platform that focuses on delivering personalized experiences throughout the healthcare process. Its platform facilitates seamless and compliant coordination among healthcare providers, incorporating predictive intelligence and real-time analytics. This enables healthcare organizations to enhance operational efficiency and foster collaboration, ultimately aiming for improved patient outcomes.
VenoStent
Series A in 2024
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Ummeed Housing Finance
Series F in 2024
Ummeed Housing Finance Private Limited is a housing finance company based in Gurugram, India, founded in 2016. The company specializes in providing home loans and loans against property specifically tailored for lower and middle-income families, particularly those with informal incomes who often face challenges in accessing organized financial services. Ummeed Housing Finance aims to enhance operational efficiency and minimize turnaround times for customers by utilizing technology in its processes. In addition to home loans and loans against property, the company also offers services for home renovation and construction, as well as insurance products, thereby supporting families in achieving their housing goals in a personalized and customer-friendly manner.
Learn To Win
Series A in 2024
Learn to Win, Inc. is a Palo Alto, California-based company that specializes in providing training programs for aviators, athletes, and various sectors, including business and defense. The company operates a mobile-first microlearning platform that transforms traditional training materials into interactive experiences. This platform enables coaches, educators, and instructors to create engaging lessons and quizzes quickly, making training accessible to all team members. Additionally, it includes real-time analytics, allowing trainers to identify mental weaknesses and training gaps, enabling timely interventions to enhance performance. Through its innovative approach, Learn to Win aims to improve learning outcomes and effectiveness in training across diverse fields.
Fibe
Series E in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.
Fibe
Secondary Market in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.
Butter Payments
Venture Round in 2024
Butter Payments is a software development company focused on addressing the issue of involuntary churn in subscription services, which results in significant revenue loss due to failed payments. With the aid of machine learning, Butter enables leading subscription businesses such as Fabletics, The Athletic, Savage x Fenty, Found, Tonal, and Hairstory to recover lost revenue, enhance authorization rates, and improve customer lifetime value. Founded in 2020 by Vijay Menon, Butter Payments is committed to transforming the landscape of subscription payments and minimizing the financial impact of payment failures. The company is supported by prominent investors including Atomic, Norwest Venture Partners, SpringTide, and Transpose Platform.
Zenas BioPharma
Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.
Legion Technologies
Venture Round in 2024
Legion Technologies, Inc. develops a workforce engagement platform that leverages artificial intelligence, big data, and cloud technology to enhance workforce management. Its flagship product, the Legion platform, offers features such as demand forecasting, labor optimization, automated scheduling, employee engagement, and time and attendance tracking. These tools help businesses improve compliance, budget control, retail sales, and workforce sharing. Targeting industries such as retail, food services, health and fitness, and hospitality, Legion enables organizations to maximize labor efficiency while enhancing employee engagement. Founded in 2016 and headquartered in Redwood City, California, the company also has offices in Hudson, Ohio; Chicago, Illinois; and Milton, Georgia. Legion Technologies is recognized for its rapid growth and innovative approach to workforce management, providing a user-friendly platform and mobile app that appeal to employees.
ScholarAI
Series A in 2024
ScholarAI stands out as a powerful tool for researchers seeking to improve their efficiency and effectiveness in academic research. With its advanced AI capabilities, it not only simplifies the research process but also enriches the quality of insights derived from literature. Whether for literature reviews or writing assistance, ScholarAI is poised to make a significant impact in the field of academic research.
Nectero Medical
Series D in 2024
Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, that focuses on treating mid-sized abdominal aortic aneurysms. Founded in 2017, the company has developed an innovative treatment designed to stabilize the growth of aneurysms and prevent their rupture. This treatment delivers a compound containing a stabilizer agent directly to the aneurysm site, which helps inhibit further breakdown and strengthens the vessel wall. By providing a safer intervention option, Nectero Medical aims to enable patients to receive timely care, significantly delaying or preventing the need for major endovascular or surgical repair.
EduForge AI
Seed Round in 2024
EduForge AI is a cutting-edge educational technology platform that harnesses the power of artificial intelligence to transform traditional learning paradigms into personalized, adaptive, and engaging educational experiences. Our platform bridges the gap between conventional education and future learning needs by providing AI-driven solutions that adapt to each learner's unique journey.
Straus Family Creamery
Venture Round in 2024
Straus Family Creamery, based in Petaluma, California, specializes in the production of organic dairy products, including milk, cream, yogurt, ice cream, butter, and sour cream. Founded in 1941, the company is committed to sustainable practices and supports family farming while revitalizing rural communities. Its range of products is designed for various customers, including fine-dining restaurants, bakeries, hotels, schools, and ice cream shops. Additionally, Straus Family Creamery offers ice cream bases and soft-serve mixes, ensuring a diverse selection of healthy dairy options. The company emphasizes the use of processed organic ingredients and often packages its milk in redeemable glass containers, marking its dedication to sustainability and quality.
Lumana
Seed Round in 2024
Lumana is an AI-powered video security and safety platform that assists organizations in optimizing their video data for enhanced visibility and emergency response. By utilizing advanced artificial intelligence, Lumana's system provides near-human-like perception, allowing organizations to react swiftly and accurately to critical events. Its innovative approach to video security management is designed to improve safety and operational efficiency for various users.
ediphi
Series A in 2024
Ediphi is a cloud-based platform that specializes in conceptual and detailed cost estimating, aimed at enhancing preconstruction processes and facilitating informed decision-making. The platform centralizes procurement and provides insights into the financial viability of designs, presenting clients with a comprehensive overview of costs along with contextual options for exploration. This approach enables clients to experience a streamlined process from the initial ideation phase through to the commencement of construction, ensuring efficiency and clarity throughout the project lifecycle.
Engrail Therapeutics
Series B in 2024
Engrail Therapeutics, Inc. is dedicated to developing and commercializing neuro drugs aimed at treating diseases of the nervous system. Founded in 2019 and based in San Diego, California, the company focuses on creating transformative medicines to alleviate the significant burden of such conditions. One of its key products is ENX-101, a preclinical compound designed to modulate a receptor for GABA, a critical neurotransmitter in the brain. Engrail Therapeutics combines biological insights with clinically meaningful solutions to advance its portfolio of therapies, utilizing a flexible transaction model to efficiently progress its drug candidates from development to commercialization.
InnerSense AI
Pre Seed Round in 2024
InnerSense AI is an application that offers personalized, AI-driven mental wellness support. It helps users track their moods, access mindfulness exercises, and connect with therapy resources anytime. The app provides a tailored mental health experience, including mood tracking, mindfulness practices, and a 24/7 chatbot for professional support. It aims to empower users to enhance their mental well-being and develop healthier coping strategies throughout their emotional journey.
ElderCare
Seed Round in 2024
ElderCare: AI-Powered Elderly Care Platform Executive Summary ElderCare is a cutting-edge platform that leverages artificial intelligence to revolutionize elderly care, creating a seamless bridge between seniors, caregivers, and family members. Our solution addresses the growing global challenge of aging populations by providing intelligent, real-time care solutions that enhance safety, improve quality of life, and offer peace of mind to families. Platform Overview Mission Statement To transform elderly care through innovative AI technology, ensuring dignity, safety, and independence for seniors while providing families with reliable, real-time care management solutions. Core Technology Components 1. Intelligent Monitoring System - Advanced fall detection algorithms - Real-time health vital tracking - Behavioral pattern analysis - Anomaly detection and early warning system - Emergency response integration 2. Smart Care Management Platform - Automated health trend analysis - Personalized care recommendations - Medication management and reminders - Activity monitoring and reporting - Sleep pattern analysis 3. Family Connection Hub - Real-time status dashboard - Instant alert notifications - Secure video communication - Care history documentation - Remote monitoring capabilities Key Benefits For Seniors - Enhanced independence and dignity - Immediate response to emergencies - Proactive health monitoring - Improved quality of life - Maintained privacy with non-intrusive monitoring For Families - Real-time peace of mind - Reduced anxiety and stress - Immediate notification of incidents - Remote care participation - Data-driven care decisions For Caregivers - Streamlined care management - Evidence-based decision making - Reduced administrative burden - Enhanced communication tools - Improved care coordination Technical Innovation AI Integration - Machine learning algorithms for pattern recognition - Predictive analytics for health trends - Natural language processing for voice commands - Computer vision for movement analysis - Deep learning for behavioral understanding Safety Features - 24/7 automated monitoring - Multi-sensor integration - Emergency service integration - Backup power systems - Data encryption and privacy protection Market Impact Current Challenges Addressed - Rising elderly population - Caregiver shortage - High cost of traditional care - Family separation - Limited healthcare resources Competitive Advantages 1. Advanced AI technology integration 2. Comprehensive care solution 3. User-friendly interface 4. Scalable platform architecture 5. Evidence-based care approaches Future Development Roadmap 1. Enhanced AI capabilities 2. Integration with healthcare providers 3. Extended IoT device compatibility 4. International market expansion 5. Advanced predictive care features Vision To become the global standard in AI-powered elderly care, creating a world where seniors can age gracefully with dignity while staying connected to their loved ones through intelligent technology. Social Impact - Improving elderly care accessibility - Reducing healthcare costs - Supporting aging in place - Strengthening family connections - Enhancing care quality standards
tvScientific
Convertible Note in 2024
TvScientific is a performance advertising platform focused on making connected TV (CTV) advertising accessible and measurable for brands and applications of all sizes. The platform utilizes data to demonstrate the true value of TV advertising while simplifying and automating the processes of CTV buying and optimization. TvScientific offers real-time reporting that allows users to monitor campaign performance effectively, ensuring that their advertising efforts achieve optimal results. Additionally, the platform features Always-On Incrementality testing, which provides insights into the incremental value generated by CTV campaigns, further assuring users that their marketing strategies are effective. By combining intuitive campaign management with digital-like measurement and attribution, TvScientific enables businesses to harness CTV as a scalable performance channel.
SK Finance
Private Equity Round in 2024
SK Finance operates as a non-banking financial institution focused on providing asset finance solutions tailored for the mid-market sector. The company serves a diverse range of clients through five primary product segments: commercial vehicles, agricultural and construction equipment, passenger vehicles, two-wheelers, and small businesses. It specializes in offering a comprehensive array of financial services, including loans and financial planning, while also supporting the establishment and growth of micro, small, and medium enterprises. Through its expert personnel, SK Finance delivers end-to-end financial assistance that emphasizes security and customer satisfaction.
Anomalo
Series B in 2024
Anomalo is a developer of an artificial intelligence-based data validation tool that helps organizations continuously inspect and validate the data entering their warehouses. The company’s solution automatically detects and explains issues in enterprise data, facilitating a seamless connection to data warehouses. By employing automated machine learning technology, Anomalo enables companies to validate and document their data with minimal configuration, eliminating the need for users to write any code. This approach streamlines the data validation process, enhancing data integrity and reliability for enterprises.
Route 92
Series F in 2023
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.
CytoVale
Series C in 2023
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
Aesthetic Partners
Private Equity Round in 2023
Aesthetic Partners is a clinical aesthetics practice management firm established in 2018 and based in Miami, Florida. The firm specializes in acquiring and partnering with high-end, physician-led medical aesthetics, cosmetic dermatology, and plastic surgery clinics across the United States. Aesthetic Partners focuses on supporting its portfolio brands through financial investment, operational expertise, and assistance with expanding their locations, ensuring a patient-centric approach in all endeavors.
Regency Healthcare
Venture Round in 2023
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.
Enable
Series D in 2023
Enable is a cloud-based software platform that specializes in rebate management for distributors, manufacturers, and retailers. Founded in 2016 and headquartered in San Francisco, California, Enable offers a solution that allows businesses to calculate, plan, and manage rebate deals effectively, thereby facilitating profitable growth. The platform provides actionable insights for more informed decision-making, streamlines the execution of trading agreements, and enhances financial reporting with transparent and auditable results. By fostering collaboration between trading partners through integrated planning and incentive programs, Enable helps companies acquire, retain, and serve their customers more efficiently.
Regency Healthcare
Secondary Market in 2023
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.
ORO Labs
Series B in 2023
ORO Labs specializes in developing a procurement automation platform aimed at enhancing traditional procurement operations. The company's software focuses on streamlining enterprise spending on critical purchases and supplier interactions, which are often chaotic and complex. ORO Labs' platform offers a user-friendly experience that provides visibility into supplier risk and spending, along with comprehensive management of purchasing processes, legal formalities, and compliance. This enables modern companies to address their procurement needs efficiently and with agility.
Guidde
Series A in 2023
Guidde is a knowledge management platform that facilitates efficient knowledge transfer for businesses, enhancing both team productivity and customer interactions. The platform enables users to collaboratively create, maintain, organize, and share video-based content that is context-aware and accessible at the point of need. By streamlining the processes of capturing and distributing knowledge, Guidde helps teams shorten the time it takes for customers to understand and utilize solutions, while also supporting continuous upskilling for employees and partners. Its innovative approach is utilized by various teams, including Customer Success, Pre Sales, and Product teams, to improve operational effectiveness and knowledge collaboration.
Diana Health
Series B in 2023
Diana Health operates a network of contemporary women's health practices designed to enhance the delivery of maternity and women’s healthcare in collaboration with hospitals. The organization focuses on empowering women by offering personalized and comprehensive care that prioritizes their involvement in decision-making. Through an individualized care program, Diana Health integrates clinical care, education, and wellness support, all facilitated by a user-friendly technology platform. This approach aims to improve clinical outcomes and streamline operations, ultimately helping women prepare for childbirth and their parenting journeys.
RightRev
Series A in 2023
RightRev provides an automated revenue recognition solution that helps businesses manage financial reporting in compliance with current accounting standards. The platform integrates seamlessly with sales operations and revenue accounting processes, facilitating accurate tracking of revenue across various models, including subscriptions, one-time sales, and services. By enhancing existing customer relationship management and configure, price, quote tools, RightRev's solution offers a comprehensive approach to revenue reporting, ensuring transparency and reducing the risk of financial misstatements. The platform is designed to support finance professionals in navigating complex revenue accounting requirements, such as those outlined in ASC 606 and IFRS 15.
Pair Eyewear
Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
HighFive Healthcare
Private Equity Round in 2023
HighFive Healthcare is a practice management service provider that provides healthcare management for dentistry practices. The company's services include targeted marketing, online scheduling, electronic check-in to surveys, and other associated services, allowing dentists to operate their business more efficiently and provide patients with superior dental care.
Vertos Medical
Series C in 2023
Vertos Medical Inc. is a medical device company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS). Founded in 2005 and headquartered in Aliso Viejo, California, the company has developed the mild device, which provides an outpatient, fluoroscopically guided treatment for LSS without the need for implants. This innovative approach allows physicians to perform lumbar decompression procedures under local anesthesia, helping to restore space in the spinal canal, alleviate pressure on nerves, and enhance patient mobility. Vertos Medical's commitment to advancing spinal care is reflected in its focus on delivering effective solutions for common spinal diseases.
oneNav
Series C in 2023
OneNav specializes in developing a mobile positioning system tailored for smartphones, wearables, and Internet of Things (IoT) tracking devices. The company's innovative system leverages the modernized L5 signaling band from navigation satellite constellations, enhancing the accuracy and reliability of position data. By incorporating artificial intelligence, OneNav provides clients with upgraded, data-rich signals that support various tracking applications, ensuring precise location services across multiple platforms.
Neura Health
Seed Round in 2023
Neura Health is a venture-backed startup focused on enhancing access to and the quality of care for individuals with neurological conditions. The company has developed a virtual neurology clinic platform that allows patients to track their symptoms and share them with licensed doctors, facilitating personalized care from the comfort of their homes. This approach aims to address the significant challenges faced in neurology, including long wait times for specialist appointments and limitations in diagnosis that often rely on self-reported data. By streamlining the process of obtaining care, Neura Health seeks to improve treatment options for conditions such as migraine and chronic headaches, while also working towards a broader goal of advancing neurological research and finding potential cures.
Ray Therapeutics
Series A in 2023
Ray Therapeutics is a company focused on developing innovative optogenetic gene therapies aimed at treating patients with blinding diseases. By creating technology that enhances the understanding of rare retinal conditions, the company strives to empower healthcare professionals to effectively diagnose, cure, and manage inherited retinal diseases. Through its commitment to advancing optogenetics, Ray Therapeutics seeks to improve the quality of life for those affected by these debilitating conditions.
Spiff
Series C in 2023
Spiff Inc. is a software company that specializes in sales commission automation through its SaaS platform. Founded in 2017 and headquartered in Sandy, Utah, with an office in Mountain View, California, Spiff offers a comprehensive solution that allows organizations to design, manage, and optimize their sales commission plans. The platform enables users to create and modify commission structures, automate data integration from various systems such as ERP and payroll, and provide sales teams with personalized dashboards to track their performance. Spiff’s software streamlines complex commission processes, enhances accuracy by eliminating errors, and supports advanced features like modeling new plans and generating detailed payroll reports. The company primarily serves finance and sales operations, sales and marketing teams, managers, and executives, facilitating improved sales performance through real-time insights and automation.
Simpplr
Series D in 2023
Simpplr Inc. is an AI-powered employee experience platform that facilitates effective communication and collaboration within organizations. Founded in 2014 and headquartered in Redwood City, California, with additional offices in the United Kingdom and India, Simpplr offers a range of services that enhance employee engagement and streamline internal communications. Its platform allows employees to access knowledge articles, collaborate on projects, post questions, and create support cases, fostering a connected workforce. Additionally, Simpplr provides implementation and onboarding services, as well as ongoing customer support, to ensure organizations can maximize the benefits of their platform. By creating virtual headquarters and company newsrooms, Simpplr helps align and engage employees across the enterprise, promoting a thriving workplace culture.
Culinary Brands
Series C in 2023
Culinary Brands is a company dedicated to creating fresh food products that delight customers. It has established exclusive partnerships with well-known global brands, including Subway and Lavazza. Additionally, Culinary Brands owns a coffee manufacturing facility, allowing it to control the quality and production of its coffee offerings. The company operates as a platform for food brands, focusing on forging partnerships within the food industry. By investing in brands that prioritize fresh, quality products, Culinary Brands aims to deliver value to consumers while also generating job opportunities through its operations.
Elevate
Series B in 2023
Elevate is an automated, AI-driven benefit account platform designed to assist account administrators, including benefit platforms, financial institutions, health plans, and third-party administrators. The company aims to modernize consumer benefits by offering an all-in-one, reliable technology solution that supports Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Elevate's platform is utilized by thousands of employers and serves hundreds of thousands of American workers and their families, streamlining the management of consumer-directed employee benefits.
SlashNext
Series B in 2023
SlashNext, Inc. specializes in cybersecurity solutions, focusing on protecting users from phishing threats. Founded in 2014 and headquartered in Pleasanton, California, the company offers an Active Cyber Defense System that delivers zero-day protection against various internet-based threats, including social engineering attacks, data exfiltration, and malware. Utilizing its patented SEER technology, SlashNext performs dynamic run-time analysis on billions of URLs daily, enabling the detection of zero-hour phishing threats. The company's comprehensive protection services include mobile phishing protection, browser phishing defense, and agentless solutions, which can be accessed through mobile apps, browser extensions, and APIs that integrate with leading endpoint management and incident response tools.
Numbers Station
Series A in 2023
Numbers Station is a software development platform that focuses on enhancing artificial intelligence workflows. It specializes in creating AI-powered solutions aimed at automating data-intensive processes, particularly for enterprise applications. The platform's advanced models are designed to deliver high-quality performance on various data tasks, facilitating the generation of valuable insights. This capability allows data professionals to make informed business decisions and maximize the value derived from their data assets.
Clever Care Health Plan
Series C in 2023
Clever Care Health Plan, Inc. is a healthcare insurance provider that specializes in Medicare Advantage plans, integrating the principles of Eastern and Western medicine. Founded in 2018 and headquartered in Westminster, California, with an additional office in Arcadia, the company offers a range of culturally sensitive healthcare solutions. Its plans include access to services such as acupuncture, herbal remedies, tai chi, and cupping, aimed at enhancing both physical and mental well-being. Clever Care connects its members with diverse networks of hospitals and healthcare providers who are attuned to their cultural needs and language preferences. The company distributes its products through brokers and sales agents, ensuring that Medicare beneficiaries receive the support and services they require.
Mintifi
Series D in 2023
Mintifi is an online lending platform in India focused on empowering small and medium businesses through accessible financing solutions. By leveraging technology and partnerships with companies like WhatsApp, Mintifi streamlines the loan process, allowing businesses to obtain funds quickly and efficiently. The platform specializes in supply chain financing, specifically targeting the last-mile distribution network. By providing flexible and affordable financing options, Mintifi enhances the purchasing experience for businesses, enabling them to manage their operations and supply chains more effectively.
SpryPoint
Private Equity Round in 2023
SpryPoint is a provider of cloud-based enterprise software specifically designed for electric, water, gas, and telecom utilities. The company aims to enhance customer service and operational efficiency for utility operators across North America. By offering a robust cloud architecture that requires no hardware, SpryPoint's solutions feature application programming interfaces, improved performance, and exceptional scalability. These offerings allow for ongoing system updates, faster implementation, and flexible pricing models. Ultimately, SpryPoint equips utilities with the tools necessary for business automation, enabling them to deliver superior service while streamlining their operations.
InfluxData
Series E in 2023
InfluxData Inc. specializes in providing open-source platforms for managing and analyzing time-series data at scale. The company is best known for InfluxDB, its time-series database designed to handle large volumes of time-stamped data generated by IoT devices, applications, networks, and containers. InfluxData also offers a suite of complementary tools, including Telegraf for data collection, Chronograf for visualization, and Kapacitor for processing and alerting. Additionally, the company provides fully-managed InfluxDB clusters through InfluxCloud and offers technical support, training, and consulting services. Founded in 2012 and based in San Francisco, California, InfluxData serves a diverse range of clients, including prominent organizations like Cisco, IBM, PayPal, and Tesla, enabling them to efficiently store and analyze real-time data for various applications.
Lavender
Series A in 2023
Lavender is a software application that provides an AI-driven email assistant designed to enhance the writing of sales emails. The platform offers features such as AI recommendations, reply optimization, and tools for integrating gifs, checking spelling and grammar, assessing spam potential, analyzing subject lines, and conducting prospect and company research. These capabilities enable sales professionals to craft more effective and impactful business emails.
GeoComply Solutions
Private Equity Round in 2023
GeoComply Solutions specializes in geolocation compliance technology, offering advanced solutions to enhance security and mitigate fraud in the digital space. The company focuses on providing clarity to businesses by monitoring suspicious activities across various industries, including daily fantasy sports, poker, casinos, sports betting, and lotteries. Their suite of products includes GeoComply Core, PinPoint, IDComply, and GeoGuard, among others, which are designed to facilitate fraud detection and ensure compliance with regulatory requirements. By prioritizing the safety of online transactions and user interactions, GeoComply Solutions aims to foster a more secure digital ecosystem for all stakeholders involved.
SetPoint Medical
Venture Round in 2023
SetPoint Medical is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices aimed at treating chronic autoimmune diseases. The company is creating a platform that stimulates the vagus nerve to activate the body's natural inflammatory reflex, leading to a systemic immune-restorative effect. This innovative approach offers an alternative treatment option for conditions such as rheumatoid arthritis and inflammatory bowel disease, with the potential for reduced risks and costs compared to traditional drug therapies. SetPoint Medical, originally known as Innovative Metabolics Inc. until its name change in 2008, aims to provide patients and healthcare providers with effective solutions for managing debilitating inflammatory diseases.
SILA Group
Private Equity Round in 2023
SILA Group is a real estate platform based in Mumbai, India, that specializes in project management and facility management services. Founded in 2010, the company caters to a diverse clientele, including corporates, real estate funds, landowners, and developers. SILA Group provides a comprehensive range of facility management services, encompassing soft services, security, helpdesk, transport, and engineering, specifically designed for corporate offices, shopping malls, residential complexes, and industrial parks. Additionally, the company offers professional cleaning services, such as deep cleaning and floor maintenance. In the realm of project management, SILA Group assists clients in navigating real estate development projects and offers advisory services to address challenges within their portfolios. Through its focus on people, processes, and culture, SILA Group aims to build a sustainable institution in the real estate sector.
Amberflo
Series A in 2023
Amberflo is a cloud metering and billing platform that specializes in usage-based pricing models. Established in 2020 by Puneet Gupta in Santa Clara, California, the company provides a highly configurable solution that allows businesses to implement real-time tracking of usage and consumption. This enables organizations to create and manage effective usage-based pricing plans, ensuring accurate, on-demand invoicing and billing. By facilitating a seamless engagement experience, Amberflo supports companies in driving revenue growth and customer adoption through Product-Led Growth strategies.
Butter Payments
Series A in 2023
Butter Payments is a software development company focused on addressing the issue of involuntary churn in subscription services, which results in significant revenue loss due to failed payments. With the aid of machine learning, Butter enables leading subscription businesses such as Fabletics, The Athletic, Savage x Fenty, Found, Tonal, and Hairstory to recover lost revenue, enhance authorization rates, and improve customer lifetime value. Founded in 2020 by Vijay Menon, Butter Payments is committed to transforming the landscape of subscription payments and minimizing the financial impact of payment failures. The company is supported by prominent investors including Atomic, Norwest Venture Partners, SpringTide, and Transpose Platform.
Monogram Health
Series C in 2023
Monogram Health, Inc. is a provider of kidney care services based in Nashville, Tennessee, specializing in the management of chronic kidney disease and end-stage renal disease. Established in 2019, the company employs an innovative in-home care delivery model that integrates evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health focuses on improving patient outcomes and quality of life while reducing medical costs through predictive analysis and next-generation artificial intelligence algorithms. It collaborates with leading health plans and risk-bearing providers to deliver care across various insurance products in 34 states, aiming to enhance the management of patients with polychronic conditions and ensure seamless transitions to dialysis and pre-emptive kidney transplants.
HeritageGuardian
Seed Round in 2023
HeritageGuardian AI is an innovative AI-powered platform specializing in cultural heritage preservation and protection. The platform leverages cutting-edge artificial intelligence technologies to safeguard humanity's cultural legacy for future generations.
Gabit
Seed Round in 2023
Gabit is a comprehensive health and wellness platform that focuses on providing personalized solutions for nutrition, fitness, and skincare. The company offers a range of services and products, including tailored meal plans, fitness programs, skincare products, and fitness wearables. Users can engage with health tech products and benefit from one-on-one consultations with experts in fitness, nutrition, and skincare, allowing them to create customized programs that support their individual health and wellness goals. Through these offerings, Gabit aims to empower users to prioritize their fitness and overall well-being.
xpedeon
Series A in 2022
Xpedeon develops software solutions specifically tailored for the construction industry, focusing on enhancing profitability and efficiency for businesses in this sector. By collaborating with leading companies, Xpedeon has created an integrated enterprise resource planning suite that addresses the unique needs of building contractors, civil engineering contractors, specialist contractors, and housebuilders. Their software facilitates digital transformation within the construction and engineering fields, enabling companies to optimize their operations and improve margins. With a commitment to industry best practices, Xpedeon offers a comprehensive range of functionalities within a single solution, distinguishing itself from other software providers in the market.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Pack Digital
Seed Round in 2022
Pack Digital is a developer tool focused on creating high-performing e-commerce storefronts through a modern frontend platform. The company provides an end-to-end infrastructure that allows merchants to easily build and manage storefronts in a low-code environment, facilitating seamless integration with existing backend commerce tools. By consolidating product information and content updates within a central system, Pack Digital simplifies the management of Progressive Web App (PWA) builds and deployments. Additionally, the company offers technical consulting and strategic services to enhance customer experiences and optimize e-commerce operations.
Channel99
Seed Round in 2022
Channel99 is a provider of a performance marketing platform aimed at enhancing the efficiency of B2B marketing. The platform connects marketing performance to specific business objectives, integrating functions across marketing, finance, and sales. By utilizing contextual benchmarking data and collaborative tools, Channel99 helps businesses measure and evaluate their marketing efforts across various channels and vendors. This approach not only minimizes marketing waste and inefficiencies but also lowers customer acquisition costs, allowing clients to improve the overall value of their marketing investments and drive predictable growth in their sales pipelines.
Celebal Technologies
Venture Round in 2022
Celebal Technologies is a leading software services company specializing in data science, big data, and enterprise cloud solutions. The firm provides IT consulting services that cater to the digital requirements of organizations, utilizing advanced technologies such as robotics, artificial intelligence, and machine learning to enhance business efficiency. Celebal Technologies focuses on delivering business intelligence, supply chain analytics, and data science-powered analytics, enabling clients to make informed decisions. Its clientele includes product independent software vendors (ISVs) and delivery organizations worldwide, benefiting from its expertise in product development and enterprise project implementations.
Rezo Therapeutics
Series A in 2022
Rezo Therapeutics is a biotechnology company that focuses on developing precision therapeutics by mapping disease networks. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo integrates various technologies, including proteomics, genetics, structural biology, chemistry, and bioinformatics, to create comprehensive molecular maps of diseases. This innovative approach enhances the identification of novel targets and therapies, particularly in oncology, where Rezo initially concentrates its efforts. The company aims to expand its therapeutic focus through collaborations and partnerships, positioning itself at the forefront of advancing treatment options across multiple disease areas.
MotherDuck
Seed Round in 2022
MotherDuck specializes in data infrastructure and analytics, providing a serverless platform designed to handle both small and large datasets. By integrating the performance of DuckDB with cloud capabilities, the company offers a user-friendly solution that facilitates collaborative data analysis. Its platform employs an embedded database to support hybrid execution, allowing users to analyze data locally and remotely. This enables businesses to effectively prototype and optimize their data strategies, enhancing their ability to derive insights and maximize profits in a streamlined environment.
WEKA
Series D in 2022
WEKA is an AI-native data platform company that provides a cloud and hardware-agnostic software solution for performance-intensive applications. Its WEKA® Data Platform enhances scalability and performance, transforming stagnant data silos into dynamic data pipelines that optimize enterprise AI, machine learning, and GPU workloads. The platform facilitates seamless data access across on-premises, cloud, edge, and hybrid multicloud environments. Serving hundreds of leading enterprises and renowned research organizations, including numerous Fortune 50 companies, WEKA addresses complex data challenges to accelerate discoveries, insights, and outcomes. The company's software-defined storage technology is tailored for high-performance and scalable file storage, making it beneficial for various industries such as life sciences, media and entertainment, financial services, and government.
MBX Biosciences
Series B in 2022
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.
ORO Labs
Series A in 2022
ORO Labs specializes in developing a procurement automation platform aimed at enhancing traditional procurement operations. The company's software focuses on streamlining enterprise spending on critical purchases and supplier interactions, which are often chaotic and complex. ORO Labs' platform offers a user-friendly experience that provides visibility into supplier risk and spending, along with comprehensive management of purchasing processes, legal formalities, and compliance. This enables modern companies to address their procurement needs efficiently and with agility.
Neocis
Series D in 2022
Neocis, Inc. is a Miami-based company that specializes in robotic guidance systems for dental implant procedures. Founded in 2009, Neocis develops the Yomi system, a robotic device designed to enhance the precision of dental surgeries. Yomi integrates computer imagery from CT scans with surgical planning, providing dental surgeons with multi-sensory feedback during procedures. This technology aims to transform dental surgery by offering a minimally invasive approach, which can lead to faster recovery times for patients. The Yomi system has received clearance from the U.S. Food and Drug Administration and is commercially available in the United States, underscoring Neocis's commitment to advancing patient care and addressing the challenges faced by dental professionals.
Enable
Series C in 2022
Enable is a cloud-based software platform that specializes in rebate management for distributors, manufacturers, and retailers. Founded in 2016 and headquartered in San Francisco, California, Enable offers a solution that allows businesses to calculate, plan, and manage rebate deals effectively, thereby facilitating profitable growth. The platform provides actionable insights for more informed decision-making, streamlines the execution of trading agreements, and enhances financial reporting with transparent and auditable results. By fostering collaboration between trading partners through integrated planning and incentive programs, Enable helps companies acquire, retain, and serve their customers more efficiently.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.